Overland Park, KANSAS4 Active Studies

Ankylosing Spondylitis Clinical Trials in Overland Park, KANSAS

Find 4 actively recruiting ankylosing spondylitis clinical trials in Overland Park, KANSAS. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
561
Enrolling

Recruiting Ankylosing Spondylitis Studies in Overland Park

RecruitingOverland Park, KANSASNCT04752774

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

The purpose of the study is to assess the safety and efficacy of increasing doses of IPN10200 with the aim to evaluate the Pharmacodynamics (PD) profile of IPN10200 and to establish the total IPN10200...

240 participants
Ipsen
View Study Details
RecruitingOverland Park, KANSASNCT05645380

Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC

This study will assess if the presence of immune system cells in and around the tumor impacts tumor shrinkage in patients receiving neoadjuvant chemoimmunotherapy for triple-negative breast cancer....

139 participants
University of Kansas Medical Center
View Study Details
RecruitingOverland Park, KANSASNCT06340451

Study to Assess the Efficacy and Safety of Iovera®° System in Subjects With Upper Extremity Spasticity

This multicenter, randomized, double-blind, sham-controlled study is designed to evaluate the efficacy and safety of the iovera° system in subjects with upper extremity spasticity. A total of approxim...

132 participants
Pacira Pharmaceuticals, Inc
View Study Details
RecruitingOverland Park, KANSASNCT04640142

Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases

Prospective, open-label, single-arm, multicentre Phase 3 study to evaluate the pharmacokinetics, efficacy, tolerability, and safety of subcutaneous human immunoglobulin (Newnorm) in patients with prim...

50 participants
Octapharma
View Study Details

About Ankylosing Spondylitis Clinical Trials in Overland Park

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 4 ankylosing spondylitis clinical trials recruiting participants in Overland Park, KANSAS. These studies are seeking a combined 561 participants. Research is being sponsored by Ipsen, University of Kansas Medical Center, Pacira Pharmaceuticals, Inc and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Overland Park — FAQ

Are there ankylosing spondylitis clinical trials in Overland Park?

Yes, there are 4 ankylosing spondylitis clinical trials currently recruiting in Overland Park, KANSAS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Overland Park?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Overland Park research site will contact you about next steps.

Are clinical trials in Overland Park free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Overland Park studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 4 active trials in Overland Park are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov